U.S. Specialty Stores Stock News

NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Latest News In Electric Vehicles - Two-Wheelers Drive Growth Amidst Infrastructure Challenges

The electric two-wheeler market is experiencing significant growth driven by the introduction of affordable new models and rising investments in charging infrastructure. As highlighted by Zion Market Research, the market's value is expected to grow from USD 529.36 million in 2024 to USD 1,228.93 million by 2034, at a CAGR of 9.81%. This sector's expansion is supported by technological advancements in battery performance and AI integration, which enhance vehicle range and features. Challenges...
NYSE:RSI
NYSE:RSIHospitality

Why Rush Street Interactive (RSI) Is Up 20.5% After Raising 2026 Guidance And Posting Record Profit

In late April 2026, Rush Street Interactive, Inc. reported past first-quarter results showing revenue of US$370.36 million and net income of US$9.07 million, with both basic and diluted earnings per share from continuing operations increasing versus a year earlier. The company also raised its full-year 2026 revenue and adjusted EBITDA guidance, pointing to stronger operating leverage from rising monthly active users and lower marketing spend as a share of revenue. We’ll now examine how Rush...
NYSE:MANE
NYSE:MANEPharmaceuticals

Is It Too Late To Consider Veradermics (MANE) After A 162% Year To Date Surge?

Wondering if Veradermics at around US$99 a share still lines up with the story you have in mind, or if the price is already baking in a lot of optimism. The stock has seen sharp recent moves, with returns of 43% over the last 7 days, 56.8% over the last 30 days, and 162.3% year to date. This can change how you think about both risk and potential reward. Recent headlines around Veradermics have focused on its position in the pharmaceuticals space and investor interest in its prospects,...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

A Look At Incyte (INCY) Valuation After Strong Q1 Beat And Reaffirmed Guidance

Incyte (INCY) is back on investors’ radar after first quarter 2026 results topped expectations, with net sales up 20% year over year and management reaffirming full year guidance alongside visible late stage pipeline milestones. See our latest analysis for Incyte. Despite the strong first quarter and upcoming product catalysts, the recent 1 day share price return of a 3.86% decline and year to date share price return of a 6.06% decline contrast with a 1 year total shareholder return of...
NYSE:GRBK
NYSE:GRBKConsumer Durables

Green Brick Partners (GRBK) Margin Compression Reinforces Cautious Narratives Heading Into Q1 2026

Green Brick Partners (GRBK) has just opened Q1 2026 reporting season with a recent run of quarterly results that show total revenue between US$497.6 million and US$567.3 million and basic EPS ranging from US$1.67 to US$2.32 over the last six reported quarters, including net income between US$74.3 million and US$103.1 million. Over the past year, the company has seen trailing twelve month revenue around US$2.1 billion and basic EPS in a tight band between US$7.09 and US$8.51. This gives you a...
NYSE:PAG
NYSE:PAGSpecialty Retail

A Look At Penske Automotive Group (PAG) Valuation After Recent Share Price Momentum

Why Penske Automotive Group is on investors’ radar Penske Automotive Group (PAG) has drawn attention after a solid run, with the stock showing positive returns over the past month and past three months, while continuing to reflect multi year total returns. See our latest analysis for Penske Automotive Group. The recent 7 day share price return of 7.20% and 30 day gain of 14.71%, on a share price of US$171.52, sit alongside a 1 year total shareholder return of 13.85% and 5 year total...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

McGrath RentCorp (MGRC) Margin Compression Challenges Bullish Rental Profitability Narratives

McGrath RentCorp (MGRC) opened 2026 with Q1 revenue of about US$198.5 million and basic EPS of roughly US$1.10, while trailing twelve month revenue stood at US$947.4 million with EPS of about US$6.30. The company reported quarterly revenue of US$195.4 million and EPS of roughly US$1.15 in Q1 2025, followed by a peak of US$256.8 million in revenue and EPS of about US$2.02 in Q4 2025 before this latest quarter. This progression provides context for how investors may assess margins as the new...
NYSE:BOX
NYSE:BOXSoftware

Assessing Box (BOX) Valuation As Mixed Returns Contrast With Higher Earnings Multiple

How Box stock has been performing Box (BOX) has seen mixed share performance recently, with a 1 day decline and gains over the past week and month, while returns over the past 3 months and year have been negative. Over the past 5 years, the stock shows a positive total return, in contrast to weaker 3 year and 1 year total returns. Year to date, the share price has also delivered a negative return. See our latest analysis for Box. At a share price of $24.20, Box has seen short term share price...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed Shifts Leadership And Adds Neurology With Noctrix Acquisition

ResMed (NYSE:RMD) appointed Aaron Bloomer as its new Chief Financial Officer, following the retirement announcement of long-serving CFO Brett Sandercock. The company also agreed to acquire Noctrix Health, a medical device firm focused on treatments for restless leg syndrome. Both announcements highlight changes in financial leadership and an expansion of ResMed’s portfolio beyond its core sleep apnea business. ResMed is best known for its sleep apnea devices and related software, a segment...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health Q1 Loss Reduction Reinforces Bullish Margin Narrative Despite Flat Revenue

Teladoc Health (TDOC) opened 2026 with Q1 revenue of US$613.8 million and a basic EPS loss of US$0.36, alongside a trailing twelve month EPS loss of US$0.96 on revenue of US$2.5 billion. Over recent quarters, the company has seen revenue move from US$629.4 million in Q1 2025 to US$613.8 million in Q1 2026, while quarterly EPS shifted from a loss of US$0.53 to a loss of US$0.36 as net income moved from a loss of US$93.0 million to a loss of US$63.8 million. This keeps the focus firmly on how...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Assessing Black Hills (BKH) Valuation After Recent Share Price Momentum

What recent performance says about Black Hills Black Hills (BKH) has drawn fresh attention after a solid run in its share price, with the stock showing gains over the past week, month, past 3 months and year to date. For investors, that recent performance raises practical questions about how the company’s current US$5.7b market value, US$2.31b in revenue and US$291.6m in net income line up with its role as a regulated electric and natural gas utility. See our latest analysis for Black...
NYSE:THG
NYSE:THGInsurance

Hanover Insurance Group Q1 Margins And EPS Strength Challenge Bearish Earnings Narratives

Hanover Insurance Group (THG) opened 2026 with Q1 revenue of US$1.7 billion and basic EPS of US$5.28, setting the tone for investors watching how its earnings story is developing. The company has seen revenue move from US$1.60 billion in Q1 2025 to US$1.70 billion in Q1 2026, while basic EPS over the same quarters went from US$3.56 to US$5.28. Together with trailing 12 month EPS of US$20.32, this points to a business where profitability and margins are firmly in focus. See our full analysis...
NYSE:BMY
NYSE:BMYPharmaceuticals

Is Bristol Myers Squibb (BMY) Still Attractively Priced After Its Strong 1 Year Share Price Gain

If you are wondering whether Bristol-Myers Squibb at US$60.59 is still offering value or if most of the opportunity is already priced in, the starting point is to understand what the current share price implies about the business. The stock has returned 2.7% over the past week, is roughly flat over 30 days with a 0.1% decline, and is up 13.3% year to date and 28.2% over the last year. This naturally raises questions about how much of this move is tied to changing expectations or perceived...